The $1,800 Hidden Cost: Menopause in the Workplace

MARKABLE Research Team · May 2026 · 5 min read

The Mayo Clinic study estimated $1.8 billion in total annual US cost, approximately $1,800 per affected employee (estimated from aggregate data) in lost productivity and adverse work outcomes. That figure, from a landmark 2023 study published in Mayo Clinic Proceedings, represents one of the most underestimated workforce costs in corporate health today.

For a company with 10,000 employees, that translates to millions in hidden losses annually. Yet fewer than 1 in 10 employers offer any form of menopause support. Here is what the research actually shows, and what the smartest companies are doing about it.

$1.8B

Estimated annual cost of menopause-related lost work time in the U.S.

Source: Faubion SS et al., Mayo Clinic Proceedings, 2023

The Mayo Clinic data: what it actually found

The 2023 study surveyed over 4,400 women at four Mayo Clinic locations. Researchers found that menopause symptoms were associated with $1,794 per employee per year in lost productivity, driven primarily by presenteeism (being at work but functioning below capacity) rather than missed days.

Key findings included:

The retention risk nobody talks about

A 2022 survey by the Biote Corporation found that up to 17% of women experiencing menopause symptoms have considered quitting their job because of them. Among those with severe symptoms, the number rises further.

The replacement math: The Society for Human Resource Management (SHRM) estimates the average cost to replace a salaried employee at 6 to 9 months of salary. For a mid-career professional earning $85,000, that is $42,500 to $63,750 per departure. When experienced women in leadership roles leave, the institutional knowledge loss compounds the financial impact.

Women ages 45 to 55 represent one of the fastest-growing segments of the workforce and increasingly hold senior positions. The timing of menopause coincides precisely with peak career responsibility, making this a leadership pipeline issue as much as a benefits issue.

Presenteeism: the bigger problem

Most employers think about absenteeism: missed days, sick leave, short-term disability. But the Mayo Clinic data found that presenteeism accounts for the majority of menopause-related productivity loss.

Presenteeism means an employee is physically present but not functioning at full capacity. Brain fog, poor sleep, difficulty concentrating, and anxiety can all reduce effectiveness without generating a single absence record. This makes the problem nearly invisible in standard HR metrics.

17%

of women with menopause symptoms have considered quitting their job

Source: Biote Corporation / Harris Poll survey, 2022

What leading employers are doing

A growing number of companies are recognizing the business case. Their approaches typically include:

Environmental adjustments

Flexibility and policy

Health benefits

The ROI of menopause benefits

The business case is straightforward. If menopause-related productivity loss costs $1,800 per affected employee per year, even a modest reduction in symptom burden yields measurable returns. Consider:

The competitive angle: As of 2026, approximately 15% of large employers offer menopause-specific benefits, according to Mercer 2023 survey data. Early adopters gain a meaningful advantage in attracting and retaining experienced talent in a tight labor market.

The bottom line

Menopause is not a niche issue. It affects over a million women entering this transition every year in the United States alone. The economic data from Mayo Clinic and other research makes the cost of inaction clear, and the ROI of intervention compelling.

The companies addressing this now are not doing it because it is trendy. They are doing it because the numbers demand it.

What is menopause costing your organization?

MARKABLE helps employers quantify the impact and track improvements in workforce wellness through objective, longitudinal monitoring.

Calculate Your ROI →
This article is for informational purposes only and does not constitute medical or financial advice. MARKABLE is a general wellness product for personal awareness and self-monitoring. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease. Statistics cited are from published research and may not reflect all workplace contexts. Always consult qualified professionals for specific guidance.